CONMED CNMD Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about CONMED's increase (decrease) in accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CONMED's increase (decrease) in accounts receivable?
- CONMED (CNMD) reported increase (decrease) in accounts receivable of -$18.61M in Q1 2026.
- How has CONMED's increase (decrease) in accounts receivable changed year-over-year?
- CONMED's increase (decrease) in accounts receivable increased by 2.0% year-over-year, from -$18.98M to -$18.61M.
- What is the long-term trend for CONMED's increase (decrease) in accounts receivable?
- Over 3 years (2021 to 2025), CONMED's increase (decrease) in accounts receivable has grown at a -36.4% compound annual growth rate (CAGR), from $9.16M to $2.36M.
- What does increase (decrease) in accounts receivable mean?
- The net change in the amount owed to the company by customers for goods or services delivered on credit during the period. An increase typically indicates rising sales or slower collections, while a decrease suggests improved cash conversion efficiency.